• 1. Copper- and DMF-mediated switchable oxidative C–H cyanation and formylation of imidazo[1,2-a]pyridines using ammonium iodide
  Xuan Li,Shoucai Wang,Jiawang Zang,Meichen Liu,Guangbin Jiang,Fanghua Ji Org. Biomol. Chem. 2020 18 9100
• 2. Synthesis of fused imidazo[1,2-a]pyridines derivatives through cascade C(sp2)–H functionalizations
  Bin Li,Nana Shen,Xinying Zhang,Xuesen Fan Org. Biomol. Chem. 2019 17 9140
• 3. Visible light induced tetramethylethylenediamine assisted formylation of imidazopyridines
  Golam Kibriya,Avik K. Bagdi,Alakananda Hajra Org. Biomol. Chem. 2018 16 3473
• 4. Insights into selenylation of imidazo[1,2-a]pyridine: synthesis, structural and antimicrobial evaluation
  Sanjeev Kumar,Nidhi Sharma,Indresh K. Maurya,Ajay Verma,Sangit Kumar,K. K. Bhasin,Rohit K. Sharma New J. Chem. 2017 41 2919
• 5. Structural modification of zolpidem led to potent antimicrobial activity in imidazo[1,2-a]pyridine/pyrimidine-1,2,3-triazoles
  Rajkumar Reddyrajula,Udaya Kumar Dalimba New J. Chem. 2019 43 16281

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Imidazopyridines Imidazopyridines
• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Imidazopyridines

Comprehensive Overview of Imidazo[1,2-a]pyridine-3-carbaldehyde (CAS No. 6188-43-8): Properties, Applications, and Research Insights

Imidazo[1,2-a]pyridine-3-carbaldehyde (CAS No. 6188-43-8) is a heterocyclic organic compound that has garnered significant attention in pharmaceutical and material science research due to its versatile chemical structure. The imidazo[1,2-a]pyridine scaffold is a privileged structure in drug discovery, often associated with bioactive molecules targeting various diseases. This article delves into the properties, synthesis methods, and cutting-edge applications of this compound, while addressing trending topics such as green chemistry, AI-driven drug design, and sustainable synthesis.

The compound's aldehyde functional group makes it a valuable intermediate for constructing complex molecules. Researchers frequently explore its reactivity in multicomponent reactions (MCRs), a hot topic in modern organic synthesis. Recent studies highlight its role in developing antiviral agents and kinase inhibitors, aligning with current demands for novel therapeutics. The imidazo[1,2-a]pyridine core also exhibits fluorescence properties, making it relevant for OLED materials and bioimaging probes—areas experiencing exponential growth.

From a synthetic perspective, 6188-43-8 can be prepared via cyclization reactions of 2-aminopyridine derivatives, with recent advancements focusing on catalyst-free and solvent-free conditions to meet green chemistry principles. These methods resonate with the pharmaceutical industry's push toward cost-effective and eco-friendly production. Computational studies using machine learning models have further optimized its synthesis pathways, reflecting the intersection of cheminformatics and experimental chemistry.

In drug development, Imidazo[1,2-a]pyridine-3-carbaldehyde derivatives show promise against neurodegenerative disorders and infectious diseases, topics dominating biomedical literature. Its structural flexibility allows for structure-activity relationship (SAR) studies, a frequent search term among medicinal chemists. Additionally, the compound's electrochemical properties are being investigated for energy storage applications, tapping into the global interest in renewable energy solutions.

Quality control of CAS 6188-43-8 involves advanced analytical techniques like HPLC-MS and NMR spectroscopy, ensuring purity for research and industrial use. Regulatory compliance with REACH and GMP standards is another critical aspect, often queried by procurement specialists. As the demand for high-value intermediates grows, this compound's market trajectory remains upward, particularly in Asia-Pacific pharmaceutical hubs.

Future directions include exploring nanocatalysis for its synthesis and derivatization, a trending subtopic in nanotechnology circles. The compound's potential in photopharmacology—where light-controlled drugs are developed—also aligns with next-generation therapeutic strategies. With ongoing patents filed for its novel applications, Imidazo[1,2-a]pyridine-3-carbaldehyde continues to be a focal point in interdisciplinary research.

• 202348-55-8(6-Methylimidazo[1,2-a]pyridine-2-carbaldehyde)
• 178488-37-4(5-Methylimidazo[1,2-a]pyridine-3-carbaldehyde)
• 175878-16-7(8-methylimidazo[1,2-a]pyridine-3-carbaldehyde)
• 30384-94-2(7-Methylimidazo[1,2-a]pyridine-3-carbaldehyde)
• 30384-93-1(2-Methylimidazo[1,2-a]pyridine-3-carbaldehyde)
• 118000-43-4(Imidazo[1,2-a]pyridine-2-carbaldehyde)
• 202348-54-7(7-Methylimidazo1,2-apyridine-2-carbaldehyde)
• 820245-84-9(2,7-dimethylimidazo1,2-apyridine-3-carbaldehyde)
• 933752-89-7(6-Methylimidazo[1,2-a]pyridine-3-carbaldehyde)
• 143982-39-2(8-Methylimidazo[1,2-a]pyridine-2-carbaldehyde)